PT1315496E - Tratamento de desordens inflamatorias - Google Patents

Tratamento de desordens inflamatorias

Info

Publication number
PT1315496E
PT1315496E PT01963202T PT01963202T PT1315496E PT 1315496 E PT1315496 E PT 1315496E PT 01963202 T PT01963202 T PT 01963202T PT 01963202 T PT01963202 T PT 01963202T PT 1315496 E PT1315496 E PT 1315496E
Authority
PT
Portugal
Prior art keywords
treatment
inflammatory disorders
inflammatory
mefloquine
administration
Prior art date
Application number
PT01963202T
Other languages
English (en)
Inventor
Skead Benjamin Mark
Bannister Robin Mark
Rothaul Alan
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of PT1315496E publication Critical patent/PT1315496E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT01963202T 2000-09-05 2001-08-31 Tratamento de desordens inflamatorias PT1315496E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
PT1315496E true PT1315496E (pt) 2005-11-30

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01963202T PT1315496E (pt) 2000-09-05 2001-08-31 Tratamento de desordens inflamatorias

Country Status (21)

Country Link
US (2) US7034028B2 (pt)
EP (1) EP1315496B1 (pt)
JP (1) JP2004508323A (pt)
CN (1) CN1309388C (pt)
AT (1) ATE302008T1 (pt)
AU (2) AU8423401A (pt)
BR (1) BR0113646A (pt)
CA (1) CA2419601A1 (pt)
DE (1) DE60112768T2 (pt)
DK (1) DK1315496T3 (pt)
ES (1) ES2245372T3 (pt)
GB (1) GB0021776D0 (pt)
HU (1) HUP0300934A2 (pt)
IL (1) IL154419A0 (pt)
MX (1) MXPA03001920A (pt)
NO (1) NO323227B1 (pt)
NZ (1) NZ524099A (pt)
PL (1) PL364030A1 (pt)
PT (1) PT1315496E (pt)
WO (1) WO2002019994A2 (pt)
ZA (1) ZA200301139B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
US20100144827A1 (en) * 2006-12-20 2010-06-10 Medwell Laboratories Ltd. C/O Ngt Technological Incubator Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
KR20130048776A (ko) * 2010-07-07 2013-05-10 유니버시티 오브 메디신 앤드 덴티스트리 오브 뉴 저지 면역조절방법
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8907518A (pt) * 1988-06-30 1991-05-28 Michael H Davis Processo para inibir a atividade do virus da imunodeficiencia humana(hiv)in vivo
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
ATE169009T1 (de) * 1994-03-09 1998-08-15 Pfizer Isoxazoline verbindung zur hemmung tnf-freigabe
AU730818B2 (en) 1997-03-07 2001-03-15 Vernalis Research Limited Use of (+)mefloquine for the treatment of malaria
EP0975345A1 (en) * 1997-11-26 2000-02-02 Cerebrus Pharmaceuticals Limited (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
EP1175216A2 (en) * 1999-04-30 2002-01-30 APT Pharmaceutical, L.L.C. Antimalarian agents for the treatment of asthma
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
CN1452488A (zh) 2003-10-29
AU2001284234B2 (en) 2004-11-04
BR0113646A (pt) 2004-01-06
WO2002019994A3 (en) 2002-05-16
EP1315496B1 (en) 2005-08-17
IL154419A0 (en) 2003-09-17
HUP0300934A2 (hu) 2003-11-28
ZA200301139B (en) 2004-03-29
HK1054324A1 (en) 2003-11-28
DE60112768T2 (de) 2006-02-02
NZ524099A (en) 2004-04-30
CN1309388C (zh) 2007-04-11
EP1315496A2 (en) 2003-06-04
PL364030A1 (en) 2004-12-13
AU8423401A (en) 2002-03-22
DE60112768D1 (de) 2005-09-22
JP2004508323A (ja) 2004-03-18
NO20030985D0 (no) 2003-03-03
NO20030985L (no) 2003-03-03
GB0021776D0 (en) 2000-10-18
US20060074106A1 (en) 2006-04-06
MXPA03001920A (es) 2004-02-12
CA2419601A1 (en) 2002-03-14
US20040029916A1 (en) 2004-02-12
NO323227B1 (no) 2007-02-05
DK1315496T3 (da) 2005-11-14
ES2245372T3 (es) 2006-01-01
US7034028B2 (en) 2006-04-25
WO2002019994A2 (en) 2002-03-14
ATE302008T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
PT1147114E (pt) Novos aralquilaminas de espirofuropiridinas uteis em terapia.
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
GT199900013A (es) Tratamiento de la disfuncion sexual femenina.
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
DK1220852T3 (da) Substituerede diazepaner
PT1315496E (pt) Tratamento de desordens inflamatorias
BR0112264B1 (pt) dispositivo de tratamento de sangue.
ATE306977T1 (de) Schaukel für behinderte
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
NO20005548D0 (no) Mykobakterieinhibitorer
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
AU2002319690A1 (en) Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
TR200003084T2 (tr) Paroxetine askorbat
AU5994699A (en) Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders
UA40336A (uk) Спосіб хірургічного лікування екстрапірамідних гіперкінезів у хворих із церебросудинною патологією
ES1043843Y (es) Generador de ruido blanco para la terapia del tinnitus.
ITGE20010007U4 (it) Apparato per trattamenti fisiologici.